More progress made towards the start of Phase III, we have now made it on to the clinicltrials.gov and there is lots of good information about the trial included there.
In particular I would draw your attention to the following
Estimated start date : June 2022
Estimated primary completion date: March 2023
Estimated study completion date: July 2023
https://www.clinicaltrials.gov/ct2/show/NCT05347147?term=invex&draw=2&rank=1
More progress made towards the start of Phase III, we have now...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.891M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 12.0¢ | 10.5¢ | $5.901K | 53.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7193 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 21500 | 1 |
View Market Depth
| Last trade - 15.59pm 19/09/2025 (20 minute delay) ? |
| IXC (ASX) Chart |